scispace - formally typeset
Journal ArticleDOI

Turning liabilities into opportunities: Off-target based drug repurposing in cancer.

Vinayak Palve, +3 more
- 01 Jan 2021 - 
- Vol. 68, pp 209-229
Reads0
Chats0
TLDR
Experimental and computational methods that are employed to specifically develop single target and network-based off-target repurposing strategies, for instance with drug combinations or polypharmacology drugs are discussed.
About
This article is published in Seminars in Cancer Biology.The article was published on 2021-01-01. It has received 33 citations till now. The article focuses on the topics: Repurposing & Precision medicine.

read more

Citations
More filters
Journal Article

Patterns of Somatic Mutation in Human Cancer Genomes

TL;DR: In this paper, the coding exons of the family of 518 protein kinases were sequenced in 210 cancers of diverse histological types to explore the nature of the information that will be derived from cancer genome sequencing.
Journal ArticleDOI

Overcoming cancer therapeutic bottleneck by drug repurposing

TL;DR: This review presents various promising repurposed non-oncology drugs for clinical cancer management and classify these candidates into their proposed administration for either mono- or drug combination therapy.
Journal ArticleDOI

Artificial intelligence, machine learning, and drug repurposing in cancer.

TL;DR: In this paper, the authors focus on the use of comprehensive target activity profiles that enable a systematic repurposing process by extending the target profile of drugs to include potent off-targets with therapeutic potential for a new indication.
Journal ArticleDOI

Network Pharmacology Approach for Medicinal Plants: Review and Assessment

TL;DR: This study is attributed to a comprehensive summary of network pharmacology based on current research, highlighting various active ingredients, related techniques/tools/databases, and drug discovery and development applications to serve as a protocol for discovering novel compounds to explore the full range of biological potential of traditionally used plants.
Journal ArticleDOI

Drugs repurposed: An advanced step towards the treatment of breast cancer and associated challenges

TL;DR: In this article , the authors provided the updated information on all the repurposed drugs candidates for breast cancer with the molecular mechanism responsible for their anti-tumor activity and discussed all the challenges that occur during the drug repurposing process.
References
More filters
Journal ArticleDOI

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

TL;DR: A subgroup of patients with non-small-cell lung cancer have specific mutations in the EGFR gene which correlate with clinical responsiveness to the tyrosine kinase inhibitor gefitinib, and these mutations lead to increased growth factor signaling and confer susceptibility to the inhibitor.
Journal ArticleDOI

Sequencing technologies-the next generation

TL;DR: A technical review of template preparation, sequencing and imaging, genome alignment and assembly approaches, and recent advances in current and near-term commercially available NGS instruments is presented.
Journal ArticleDOI

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

TL;DR: The results indicate that large, annotated cell-line collections may help to enable preclinical stratification schemata for anticancer agents and the generation of genetic predictions of drug response in the preclinical setting and their incorporation into cancer clinical trial design could speed the emergence of ‘personalized’ therapeutic regimens.
PatentDOI

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

TL;DR: In this paper, the rictor-mTOR complex was used to identify compounds which modulate Akt activity mediated by the Rictor mTOR complex and methods for treating or preventing a disorder that is associated with aberrant Akt activation.
Journal ArticleDOI

The cancer genome atlas pan-cancer analysis project

John N. Weinstein, +379 more
- 01 Oct 2013 - 
TL;DR: The Pan-Cancer initiative compares the first 12 tumor types profiled by TCGA with a major opportunity to develop an integrated picture of commonalities, differences and emergent themes across tumor lineages.
Related Papers (5)
Trending Questions (1)
What is the challenge of targeted drug therapy??

The challenge of targeted drug therapy is the limited duration of clinical responses and the need for new drugs.